Infectious disease
EBV BZLF-1 190-197 (HLA-B*08:01) RAKFKQLL
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Product number: EP07899_1
Description
Antigen peptide RAKFKQLL for stimulation of human EBV BZLF-1(190-197)-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-B*0801 allele. RAKFKQLL is a linear peptidic epitope (epitope ID53128) studied as part of Trans-activator protein BZLF1 from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
TechData
| Sequence: | RAKFKQLL |
| Gene: | BZLF1 |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Trans-activator protein BZLF1 |
| UniProt Id: | P03206 |
| Species: | Epstein-Barr virus (EBV; Human herpesvirus 4) |
| Allele: | HLA-B*08:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Infectious disease, Cancer, Neuroscience |
| Purity: | 95% HPLC-MS |